These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 21508940

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Transporter-mediated drug uptake and efflux: important determinants of adverse drug reactions.
    Zolk O, Fromm MF.
    Clin Pharmacol Ther; 2011 Jun; 89(6):798-805. PubMed ID: 21471963
    [Abstract] [Full Text] [Related]

  • 3. Elucidating mechanisms of drug-induced toxicity.
    Liebler DC, Guengerich FP.
    Nat Rev Drug Discov; 2005 May; 4(5):410-20. PubMed ID: 15864270
    [Abstract] [Full Text] [Related]

  • 4. [Pharmacogenomics for adverse drug reactions].
    Saito Y, Sai K, Sawada J.
    Nihon Rinsho; 2010 Aug; 68 Suppl 8():263-8. PubMed ID: 20979280
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Adverse effects of drugs induced by transporter-mediated tissue distribution and elimination].
    Kusuhara H.
    Chudoku Kenkyu; 2008 Jan; 21(1):13-27. PubMed ID: 18277549
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Epigenetics in humans: an overview.
    Rivera RM, Bennett LB.
    Curr Opin Endocrinol Diabetes Obes; 2010 Dec; 17(6):493-9. PubMed ID: 20962634
    [Abstract] [Full Text] [Related]

  • 9. Combinatorial pharmacogenetics.
    Wilke RA, Reif DM, Moore JH.
    Nat Rev Drug Discov; 2005 Nov; 4(11):911-8. PubMed ID: 16264434
    [Abstract] [Full Text] [Related]

  • 10. Adverse drug reactions in utero: perspectives on teratogens and strategies for the future.
    Mitchell AA.
    Clin Pharmacol Ther; 2011 Jun; 89(6):781-3. PubMed ID: 21593753
    [Abstract] [Full Text] [Related]

  • 11. Adverse drug reactions.
    Gajula V, Bogu S, Vutukuru A.
    Indian J Cancer; 2009 Jun; 46(3):255-6. PubMed ID: 19574690
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Out of Africa and into epigenetics: discovering reprogramming drugs.
    Jones P.
    Nat Cell Biol; 2011 Jan; 13(1):2. PubMed ID: 21173799
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Adverse drug reactions: moving from chance to science.
    Haller C, James LP.
    Clin Pharmacol Ther; 2011 Jun; 89(6):761-4. PubMed ID: 21593747
    [No Abstract] [Full Text] [Related]

  • 16. Designing drugs to avoid toxicity.
    Smith GF.
    Prog Med Chem; 2011 Jun; 50():1-47. PubMed ID: 21315927
    [No Abstract] [Full Text] [Related]

  • 17. With your genes? Take one of these, three times a day.
    Abbott A.
    Nature; 2003 Oct 23; 425(6960):760-2. PubMed ID: 14574377
    [No Abstract] [Full Text] [Related]

  • 18. Molecular mechanisms of drug transporter regulation.
    Tirona RG.
    Handb Exp Pharmacol; 2011 Oct 23; (201):373-402. PubMed ID: 21103976
    [Abstract] [Full Text] [Related]

  • 19. Conference Scene: An international showcase of the rapid expansion of epigenetics.
    Choi JK, Kim YJ.
    Epigenomics; 2009 Dec 23; 1(2):235-7. PubMed ID: 22122701
    [No Abstract] [Full Text] [Related]

  • 20. Are predictive biomarkers of toxicity worth having? An economic model.
    Jones B, Smith DA, Schmid EF.
    Xenobiotica; 2012 Jan 23; 42(1):4-10. PubMed ID: 21970747
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.